Back to TEVA Stock Lookup

Teva Pharma (TEVA) –

Sep 17, 2014 09:00 AM BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Demonstrates the Safety and Efficacy of OpRegen® in Preclinical Animal Studies
Sep 16, 2014 06:30 AM OncoGenex Announces Completion of Patient Enrollment in the Phase 3 AFFINITY Trial of Custirsen in Combination with Cabazitaxel/Prednisone as Second-line Chemotherapy in Men with Metastatic Castrate-R
Sep 12, 2014 09:18 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 12
Sep 12, 2014 09:00 AM Teva Presents Gene Expression Analysis at Joint Actrims-Ectrims Meeting Demonstrating Copaxone® (Glatiramer Acetate Injection) Has a Complex Profile
Sep 12, 2014 08:47 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 12
Sep 12, 2014 08:14 AM Teva Pharma (TEVA), Active Biotech Update on Safety of Laquinimod Phase 2 as RRMS Treatment
Sep 12, 2014 08:00 AM Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
Sep 11, 2014 11:21 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 11
Sep 11, 2014 09:30 AM Teva Pharma (TEVA) Reports GLACIER Study Primary Endpoint Achieved
Sep 11, 2014 09:29 AM Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Compared to D
Sep 10, 2014 02:30 PM Teva Pharma (TEVA) Reports Health Canada Approves Application for Generic Cipralex
Sep 8, 2014 09:48 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 08
Sep 8, 2014 08:04 AM Teva Pharma (TEVA) Issues Positive Update from Reslizumab Phase III
Sep 8, 2014 08:00 AM Successful Completion of Phase III Program for Teva’s Reslizumab Two More Phase Iii Studies Support the Benefits of Reslizumab Treatment in Asthma Patients with Eosinophilia
Sep 4, 2014 04:38 PM ISI Group Starts Teva Pharma (TEVA) at Buy
Sep 4, 2014 10:43 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 04
Sep 4, 2014 10:26 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 04
Sep 4, 2014 08:06 AM Teva Pharma (TEVA) Launches Generic Baraclude Tabs (BMY)
Sep 4, 2014 08:00 AM Teva to Present at the Morgan Stanley Global Healthcare Conference
Sep 4, 2014 08:00 AM Teva Announces Launch of Generic Baraclude® Tablets, 0.5mg and 1mg, in the United States
Sep 3, 2014 09:57 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 03
Sep 3, 2014 09:03 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 03
Sep 3, 2014 08:54 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 03
Sep 3, 2014 08:00 AM Data to be Presented at MS Boston 2014: Joint ACTRIMS-ECTRIMS Meeting Underscore Teva’s Commitment to Developing Solutions to Meet the Needs of the Multiple Sclerosis Community
Sep 3, 2014 08:00 AM Teva Launches SYNCareTM Home Administration Support Program for Patients on SYNRIBO® (Omacetaxine Mepesuccinate) for Injection
Sep 3, 2014 06:21 AM Teva Pharma (TEVA) Receives Favorable Verdict from U.K. Court in Patent Case vs AstraZeneca (AZN)
Sep 3, 2014 02:00 AM Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca
Sep 2, 2014 08:49 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 02
Sep 2, 2014 08:01 AM Teva’s Reslizumab Delivers Clinically and Statistically Significant Reduction in Asthma Exacerbations in Two Pivotal Phase III Studies
Aug 28, 2014 11:22 AM Mylan (MYL) Files ANDA for Generic Copaxone 40-mg/mL Injection
Aug 21, 2014 04:01 PM OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer
Aug 21, 2014 03:09 PM U.S. DEA Moves to Restrict Hydrocodone-Combination Prescriptions (TEVA) (MNK) (ABBV)
Aug 19, 2014 01:55 AM Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company
Aug 14, 2014 08:01 AM Rosenstein's JANA Partners 13F Confirms Apache (APA), Exits GM (GM), Enters FMC Corp (FMC) and Motorola Solutions (MSI) (more...)
Aug 7, 2014 04:01 PM OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2014
Aug 7, 2014 12:43 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Aug 07
Aug 7, 2014 12:07 PM Teva Pharma (TEVA) Receives First Paragraph IV Notice Related to COPAXONE (RDY)
Aug 7, 2014 12:04 PM Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation
Aug 7, 2014 06:30 AM OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer
Aug 5, 2014 10:52 AM Notable Analyst Rating Changes 08/05: (LO) (HIMX) (SMA) Upgraded; (ESI) (OCN) (LRN) Downgraded
Aug 5, 2014 08:16 AM Maxim Group Assumes Coveraege on Teva Pharma (TEVA) at Buy
Jul 31, 2014 11:01 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Jul 31
Jul 31, 2014 07:42 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Jul 31
Jul 31, 2014 07:03 AM Teva Pharmaceutical (TEVA) Tops Q2 EPS by 2c; Boosts FY14 EPS Outlook
Jul 31, 2014 07:00 AM Teva Reports Second Quarter 2014 Results
Jul 30, 2014 03:07 PM Trading Radar for 07/31: Exxon (XOM) , Tesla (TSLA), LinkedIn (LNKD), Expedia (EXPE), McKesson (MCK) Report
Jul 30, 2014 02:15 PM All Proposals Approved at Teva's Annual Meeting of Shareholders
Jul 30, 2014 01:56 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Jul 30
Jul 23, 2014 09:24 AM Deutsche Bank Starts Teva Pharma (TEVA) at Buy
Jul 21, 2014 11:23 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Jul 21

Back to TEVA Stock Lookup